Previous close | 159.32 |
Open | 159.78 |
Bid | 159.06 x 800 |
Ask | 159.08 x 1200 |
Day's range | 158.60 - 160.78 |
52-week range | 109.16 - 173.65 |
Volume | 2,650,394 |
Avg. volume | 8,196,530 |
Market cap | 418.749B |
Beta (5Y monthly) | 0.72 |
PE ratio (TTM) | 28.91 |
EPS (TTM) | 5.51 |
Earnings date | 20 Apr 2021 |
Forward dividend & yield | 4.04 (2.55%) |
Ex-dividend date | 22 Feb 2021 |
1y target est | 185.23 |
Merck (MRK) is stepping up to help Johnson & Johnson (JNJ) produce its COVID-19 vaccine, which was authorized last weekend.
J&J CEO Alex Gorsky joins Yahoo Finance to discuss the company's successful journey to authorization of a COVID-19 vaccine.